Form 8-K - Current report:
SEC Accession No. 0001213900-25-115921
Filing Date
2025-11-28
Accepted
2025-11-28 13:00:50
Documents
15
Period of Report
2025-11-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0267546-8k_inmune.htm   iXBRL 8-K 46630
2 EMPLOYMENT AGREEMENT, DATED NOVEMBER 26, 2025, BETWEEN INMUNE BIO INC. AND DAVID ea026754601ex10-1_inmune.htm EX-10.1 64376
3 EMPLOYMENT AGREEMENT, DATED NOVEMBER 26, 2025, BETWEEN INMUNE BIO INC. AND CORY ea026754601ex10-2_inmune.htm EX-10.2 62877
4 EMPLOYMENT AGREEMENT, DATED NOVEMBER 26, 2025, BETWEEN INMUNE BIO INTERNATIONAL ea026754601ex10-3_inmune.htm EX-10.3 89950
  Complete submission text file 0001213900-25-115921.txt   491837

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE inmb-20251126.xsd EX-101.SCH 3017
6 XBRL LABEL FILE inmb-20251126_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE inmb-20251126_pre.xml EX-101.PRE 22360
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0267546-8k_inmune_htm.xml XML 3687
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 251534326
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)